Sensus Healthcare Inc. Overview

Sensus Healthcare, Inc., a company operating in the Health Care Equipment & Supplies sector, specializes in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids. The company is known for its use of superficial radiation therapy in its operations, which it conducts on a global scale.

Financial Snapshot

As of August 10, 2025, Sensus Healthcare Inc. closed at a price of $3.18 on the Nasdaq exchange. The company’s market capitalization stands at approximately $52,295,228. Over the past year, the stock has experienced significant volatility, with a 52-week high of $9.329 recorded on November 24, 2024, and a 52-week low of $3.1 on August 7, 2025. The price-to-earnings ratio is currently 31.8.

Industry Context

Operating within the Health Care sector, Sensus Healthcare Inc. focuses on providing innovative solutions for skin cancer treatment. The company’s emphasis on superficial radiation therapy positions it uniquely within the medical device industry, catering to a specific need in the healthcare market.

Conclusion

Sensus Healthcare Inc. continues to play a significant role in the medical device industry, particularly in the treatment of skin conditions. Despite recent stock price fluctuations, the company maintains a presence in the global market, leveraging its specialized technology to address critical healthcare needs.